Explore
Validate
LearnNB600-1457
antibody from Novus Biologicals
Targeting: CD44
CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB600-1457 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB600-1457, RRID:AB_789125
- Product name
- CD44 Antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant protein (Human)
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.5 ml
- Concentration
- 0.2 mg/ml
Submitted references A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages.
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity.
Sieve I, Ricke-Hoch M, Kasten M, Battmer K, Stapel B, Falk CS, Leisegang MS, Haverich A, Scherr M, Hilfiker-Kleiner D
Vascular pharmacology 2018 Apr;103-105:16-28
Vascular pharmacology 2018 Apr;103-105:16-28
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity.
Zahreddine HA, Culjkovic-Kraljacic B, Emond A, Pettersson F, Midura R, Lauer M, Del Rincon S, Cali V, Assouline S, Miller WH, Hascall V, Borden KL
eLife 2017 Nov 7;6
eLife 2017 Nov 7;6
No comments: Submit comment
No validations: Submit validation data